Authors' Response to the Letter by Lamarca et al. Entitled 'temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration' Regarding 'activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms'

Autor:	Chatzellis, E. Daskalakis, K. Angelousi, A. Tsoli, M. Alexandraki, K.I. Wachula, E. Meirovitz, A. Maimon, O. Grozinsky-Glasberg, S. Gross, D. Kos-Kudła, B. Koumarianou, A. Kaltsas, G.
Jazyk:	angličtina
Rok vydání:	2020
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______2127::8970bd5344aa491d3ac36b8822442d90 https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2997674 Zobrazit plný text záznamu